



Medulloblastoma is a malignant cerebellar tumor that is commonly treated with the use 
of radiation treatment. While most tumors are sensitive to treatment, approximately 20% of 
medulloblastoma patients experience recurrence and die from their tumors.  The cause of 
treatment failure in these patients is unknown. The purpose of my research was to examine if the 
developmental timing of the beginning of tumor formation alters the effectiveness of radiation 
therapy. I used a mouse model of medulloblastoma in which an oncogene called SmoM2 can be 
activated at specific points during in utero brain development. SmoM2 is a mutated, 
constitutively active receptor in the Sonic hedgehog pathway and mice with activated SmoM2 
develop medulloblastoma in the first week after they are born. I quantified the survival time of 
SmoM2 mice using Kaplan-Meier analysis, and analyzed the tumors using 
immunohistochemistry, Western blot, and microarray gene expression studies. My results show 
that the radiation sensitivity of SmoM2-driven tumors depends on when the SmoM2 gene is 
activated during development. Mice in which the SmoM2 gene was activated earlier in 
development exhibited poor survival, persistent tumors, and more heterogeneous gene expression 
after radiation, which may contribute to an enhanced ability to withstand radiation-induced 
damage. Understanding the attributes that lead to therapy resistance may allow for identification 
of resistant tumors pre-treatment, aiding in more effective clinical outcomes. 
 
INTRODUCTION 
Medulloblastoma (MB) is a malignant cerebellar tumor that occurs most often in 
children. It is commonly treated with the use of radiation therapy (RT). However, while most 
tumors are sensitive to treatment, approximately 20% of patients die from tumor recurrence post-
Wu 2 
 
treatment. The causes of these variable responses to treatment are unknown. These differences 
can be modeled and studied through mouse models of MB, by expressing genes known to be 
involved with MB formation. Medulloblastomas can be grouped by gene expression, and one 
group demonstrates activation of genes that are targets of the Sonic Hedgehog (SHH) signaling 
pathway (Li et al., 2013).  
 In vertebrates, the SHH pathway is important for regulating normal development of the 
cerebellum (Dahmane and Ruiz, 1999; Lewis et al., 2004). SHH-subgroup MB derives from 
abnormal proliferation of cerebellar granule neural progenitors (CGNPs). CGNPs proliferate and 
differentiate through the first year after birth for humans and postnatal day 15 for mice (Schuller 
et al., 2009). Hyperactivation of this pathway plays a role in 25-30% of human medulloblastoma 
cases (Pietsch et al., 1997; Haldipur et al., 2012; Hatten and Roussel, 2011). To study MB, 
downstream effectors of the Shh pathway can be manipulated. Hyperactivation of SHH signaling 
causes medulloblastomas to form in transgenic mice, providing a genetically tractable in vivo 
tumor model (Schuller et al., 2008). In particular, the trans-membrane receptor Smoothened 
(Smo) has been extensively used to this effect (Mao et al., 2006). The oncogene SmoM2 is a 
mutation of Smo that results in constitutive expression of the receptor, leading to uncontrolled 
proliferation and tumor formation (Dey et al., 2012).  
We utilized Cre drivers hGFAP-cre and Math1-cre to express the SmoM2 gene at 
different time points during in-utero development. hGFAP-cre; SmoM2 (G-Smo) mice activate 
SmoM2 at the pluripotent stem cell stage, through use of the promoter for the glial fibrillary 
acidic protein (GFAP). Pluripotent stem cells which are positive for GFAP give rise to neurons 
throughout the central nervous system, including the cerebellum (Casper and McCarthy, 2006). 
Alternatively, Math1-cre; SmoM2 (M-Smo) mice do not activate the SmoM2 oncogene until 
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cells are committed neural progenitors (Salsano et al., 2004). Previous work by our lab has 
shown that both G-Smo and M-Smo mice develop tumors of similar size and severity by 
postnatal day 12 (P12). Tumors are pathologically similar and expand throughout the entire 
cerebellum. Left untreated, G-Smo mice succumb to tumor burden by around P18 and M-Smo by 
P23. In this investigation, I exposed both genotypes to RT with the aim of determining the 
effects of timing of oncogenesis, or the activation of the cancer-causing gene, on the tumors’ 
response to radiation. Tumor response was analyzed using mouse survival, 
immunohistochemistry (IHC), histology, Western blot, and microarray. Histone modifications 
before and after RT were also examined to discern whether epigenetic markers play a role in 
tumor treatment response. Because the oncogene SmoM2 is activated in utero, we hypothesized 
that histone and chromatin organization occurring during development at that time may result in 




G-Smo and M-Smo tumor mice were radiated at P12. Mice were selected by appearance, 
with tumor mice exhibiting shaky posture and a bulge on the head. Mice were anesthetized using 
a continuous flow of 1.5% isofluorane inside a small animal research irradiator. 10 Gy of broad 
beam radiation was delivered to each mouse over 3.5 minutes, with a lead plate limiting radiation 
to a 1 cm gap at the posterior of the head. Post radiation, mice were kept in a holding cage for 
recovery before being returned to original cages. Mice were sacrificed at 1 hour, 4 hours, 24 
hours, 48 hours, and 6 days post-radiation. Half of the brain was drop-fixed in 4% 
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paraformaldehyde. The cerebellum was removed from the remaining half of the brain and used 
for Western blot analysis.  
Immunohistochemistry  
After fixation, mouse brain tissue was transferred to phosphate-buffered saline (PBS), 
followed by 70% ethanol and 50% ethanol. The tissue was then embedded in paraffin and 
sectioned. Slides were deparaffinized using Histoclear, and rehydrated using a gradual ethanol 
gradient from 100% to 95% to 70% ethanol. Slides were then heated in a pressure cooker for 15 
minutes in a 10 mM citrate buffer of pH 6.0, before being transferred to PBS. The primary 
antibodies for pH2Ax and cleaved Caspase 3 were then applied separately. Nuclei were 
counterstained with DAPI (4′6-diamino-2-phenylindole) diluted 200 ng/ml in PBS. A Leica 
epifluorescence DM5000B microscope was used to visualize the slides, and stained slides were 
scanned using an Aperio ScanScope XT. For TUNEL staining, slides were first permeabilized in 
proteinase K (20 µg/mL in tris), then washed with ddH2O before staining was completed 
following manufacturer protocol (Click-iT TUNEL Alexa Fluor Imaging Assay). 
Western Blot 
Cerebellar tumor samples were lysed in lysis buffer using a sonicator. Protein 
concentrations were determined via bicinchoninic acid assay and 15 ug were deposited into the 
wells of a 12-well SDS–polyacrylamide gel. The gel was then transferred to a PVDF membrane. 
A SNAP-ID device was used to apply primary antibodies for ATR, phosphorylated p53, cleaved 
Caspase 3, pH2Ax, H3K4, H3K9, H3K27, H3K36, H2AK5, and H2BK5. β-actin was used to 
confirm equal protein concentrations. HRP-conjugated anti-rabbit and anti-mouse IgG were used 
as secondary antibodies. The membrane was activated using ECL and ECL Prime and visualized 
with chemiluminescence and autoradiography.  
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RNA Isolation and Microarray 
Radiated and non-radiated mice were sacrificed two hours after radiation and tumor 
tissue was dissected and frozen at -80ᵒC until RNA isolation. RNA isolation was completed 
using the Qiagen RNeasy Mini Kit (50) RNA Isolation Kit according to manufacturer protocol. 
Finished samples were diluted to approximately 100ng/uL and sent to Lineberger Cancer Center 
for quality control. Microarray was completed on an Affymetrix Mouse Gene 2.1
st
 array 
according to manufacturer protocol. Gene expression analysis was completed using Partek 
Genomics Suite 6.6. 
 
RESULTS 
Survival after RT 
The effect of RT on each 
genotype’s survival was charted 
using a Kaplan-Meier plot (Fig.1). 
Untreated M-Smo mice (n=12) had a 
mean survival time of 23.3 days ± 
2.5 days. With radiation, mean 
survival was increased to 38.5 ± 6.0 
days (n=24), with 3 mice surviving 
past 100 days, nearly symptom-free. 
Radiated G-Smo mice exhibited no 
difference in survival from their control littermates, with an untreated mean survival of 17.2 ± 
0.5 days (n=23) and a radiation treated mean survival of 16.8 days ± 1.0 days (n=9).   
 
 




Baseline cell count  
To examine if 
baseline 
differences in the 
two tumor types 
might account for 
the difference in 
survival benefit, 
non-radiated slides of G-Smo and M-Smo tumors were sent to the Translational Pathology Lab 
for a cell count of pH2Ax (indicative of DNA damage) and cleaved Caspase 3 (indicative of 
Caspase-mediated apoptosis) positive nuclei. A t-test was performed for differences in cC3 
expression between the two genotypes with p>0.05, indicating that there was not a statistically 
significant difference in baseline levels of apoptosis between non-radiated G-Smo and M-Smo 
mice. A t-test was unable to be performed for baseline differences in pH2Ax-positive nuclei, due 
to a staining error in one of the G-Smo samples. However, levels of pH2Ax appeared similar 
between the two genotypes as well.  
 H&E progression 
  
Figure 2: Baseline cell counts for control G-SmoM2 (n=5) and M-SmoM2 (n=5). 
pH2Ax and cC3. 
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Post radiation, overall tumor response was followed through immunohistochemistry and 
histology. H&E stains were used to visualize overall cell density and tumor progression. Both G-
Smo and M-Smo mice experienced a decrease in cell density of the tumor, which is ordinarily 
hypercellular. Both tumors adopted a slightly spongy appearance by 24 hours after radiation. By 
6 days after radiation treatment, tumors in G-Smo mice had regained hypercellularity and 
appeared indistinguishable from control, non-radiated G-Smo tumors. Alternatively, M-SmoM2 
tumors greatly decreased in size or were altogether gone by 6 days after radiation. 
 
pH2Ax progression 
pH2Ax allowed for visualization of DNA damage in the tumor post radiation. In both 
genotypes, the tumor showed drastically more pH2Ax signal compared to neighboring normal 
brain tissue, indicating increased sensitivity of tumor tissue to radiation. Both G-Smo and M-
   
 
 
Figure 3: Progression of tumors post-radiation, time points as marked. G-Smo (top) vs. M-
Smo (bottom). H&E.  
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Smo tumors showed intense signal for pH2Ax at 1 
hour, with the strongest signal occurring at 4 hours. 
In both genotypes, DNA damage appeared 
extensive and spread evenly throughout the tissue. 
p53 
p53, a tumor suppressor protein, is often 
activated in response to DNA damage to arrest 
progression of the cell cycle, activate DNA repair, 
and induce apoptosis if damage is extensive. 
Presence of p53 positive signal appeared 
similar in non-radiated G-Smo and M-SmoM2 
mice. Both genotypes experienced a 
substantial increase in p53 by 4 hours post 
radiation, and a smaller increase in 
phosphorylated p53 (Fig. 5). M-Smo signal of 
p53 appeared more homogenous than did G-
Smo signal.  
cC3 progression 
In the case of extensive DNA 
damage, apoptosis is often activated. 
Programmed cell death in the G-Smo and M-
Smo mice was evaluated two ways: cleaved 
 
 
Figure 4: pH2Ax. Progression of G-Smo (top) vs M-
Smo (bottom) post radiation. 
 
Figure 5: p53 and phosphorylated p53 (pp53) for G-Smo 
(top) and M-Smo (bottom). 10x. 
 
Figure 6: Progression of G-Smo (top) vs M-Smo (bottom) 
post radiation as seen with cleaved Caspase 3. 
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Caspase 3 (cC3) and presence of TUNEL (terminal deoxynucleotidyl transferase-dUTP nick end 
labeling). Caspases are a method of mediating apoptosis and caspase 3 is cleaved upon initiation 
of programmed cell death. cC3 signal appeared 
by 4 hours post-irradiation and was fairly 
prominent for both genotypes (Fig. 7). Positive 
nuclei were more evenly dispersed in the M-
Smo mice, whereas the G-Smo exhibited a 
more patchy appearance, with small regions of 
the tumor showing minimal signal and evading 
apoptosis.  
TUNEL makes use of the observation 
that one of the steps of apoptosis is degradation 
of the cell’s DNA. The enzyme terminal 
deoxynucleotidyl transferase (TdT) adds 
fluorescently modified nucleotides to the 3’ 
ends of fragmented DNA, indicating when a 
cell has committed to undergoing apoptosis. 
This allows for detection of cells that may not 
undergo caspase-mediated apoptosis. TUNEL 
stains for G-Smo and M-Smo revealed similar activation at baseline level without radiation. By 4 
hours after radiation, both genotypes had prominent TUNEL signal (Fig 8). Again, signal from 
M-SmoM2 tumors appeared more evenly distributed. M-Smo mice also appeared to have more 
positive nuclei overall, indicating greater apoptosis at 4 hours. 
  
     
 
Figure 7: G-SmoM2 (left) compared to M-SmoM2 
(right); cleaved Caspase 3, 4h post radiation 
 





To examine protein levels in the radiated mice, 
Western blots for ATR, phosphorylated p53, and cC3 
were performed. ATR is a serine/threonine protein kinase 
that senses DNA damage and activates cell cycle arrest. 
ATR signal was found to decrease in the G-Smo mice 
and increase in M-Smo mice from 1 hour to 4 hours after 
RT. Phosphorylated p53 levels increased from 1 to 4 
hours post RT in both M-Smo and G-Smo, indicating 
initiation of the pathway in both genotypes. cC3 appeared 
at 4 hours with strong signal for both 
genotypes, particularly in M-Smo mice, 
confirming histological observations. 
 Western blots for histone 
modifications were performed to 
examine differences in epigenetic 
markers between the genotypes without 
radiation. There appeared to be increased signal for 
methylated H3K9 for the G-Smo compared to M-Smo 
mice. Within the other three methylated histone 3 
markers H3K4, H3K27, and H3K36, similar signal was 
observed for both genotypes. Variation within mice of 




Figure 9: Western blot analysis of A. 
ATR, B. phospho p53 C. cleaved Caspase 
3 
A.  B.  
          M-Smo      G-Smo        M-Smo     G-Smo  
 
C.      D.  
           M-Smo       G-Smo      M-Smo       G-Smo 
 
Figure 10: Western blots of methylated histone 3 lysine 
residues. Three replicates of non-radiated M-Smo mice are 
shown on the left side, and three replicates of non-radiated G-
Smo mice are shown on the right side of each blot. The histone 
resides are as follows: A. H3K4; B. H3K9; C. H3K27; D. 
H3K36.  
A.  
          M-Smo         G-Smo  
B.  
            M-Smo         G-Smo 
  
Figure 11: Western blots of acetylated 
histone 2A lysine residues. M-Smo 
replicates are on the left side and G-Smo 
replicates are on the right side. Histone 




H3K9 and H3K27.  
 Acetylated H2BK5 appeared stronger for G-Smo than M-Smo and also contained within-
genotype variability. Alternatively, H2AK5 appeared similar between G-Smo and M-Smo. 
Ponceau staining was done to confirm that the same protein amount was deposited into each 
well, as β-actin was developed too strongly to provide conclusive evidence.  
 
Microarray 
Differences in the transcriptional profile of each 
genotype before and after RT were examined by 
isolating RNA from tumor samples. This resulted in a 
comparison between four groups: M-Smo no RT, M-
Smo with RT, G-Smo no RT, and G-Smo with RT. All 
RNA samples were checked by Lineberger Cancer Center for quality control (n=24, 6 per group) 
before microarray analysis. Two defined peaks for 18S, representing the small ribosomal RNA 
subunit, and 28S, the large ribosomal RNA subunit, were characteristic of each of the samples 
submitted, with all samples having a 28S/18S ratio of 1.9 or higher. RNA integrity numbers 
ranged from 9.60-10.0.  Both of these parameters indicated acceptable quality and purity of RNA 
for further experimental assays. 
 




                                                                
Principle component analysis of transcriptional profiles after RT indicated that despite 
pathologically identical tumors, G-Smo and M-Smo tumors still have distinct molecular 
differences and reactions to treatment (Fig. 13). The circled data points represent the G-Smo 
mice after RT, which appear to vary more before treatment but have a more distinct, 
distinguishable response after treatment. Post radiation, 110 genes in the G-Smo tumors were 
found to exhibit a twofold change and 48 genes were found to exhibit a twofold change in M-
Smo tumors (Fig. 14). Of these, the vast majority of genes with altered expression by M-Smo 
were also altered by G-Smo, whereas the reverse was not true. Some genes, such as p21, a cell 
cycle regulating protein controlled by p53, expressed similar changes between the two genotypes 
(Fig. 15). This corresponds to the similar activations of p53 witnessed for both genotypes via 
Western blot and IHC. However, many of the altered gene expressions were unique to G-Smo 
tumors. Among these differences, 14 histone family related genes were observed to have a 
 
 
Figure 13: Principle component analysis of G-Smo 






Figure 14: Number of genes displaying a twofold 
change after RT.  
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twofold change in G-Smo tumors as opposed to 2 histone-family genes in the M-Smo tumors. 
RT also appeared to have a more defined effect on intensity of histone gene expression among 










Shh-based MB tumors have been well-characterized as one of four distinct MB 
subgroups, with each subgroup possessing unique gene expression profiles, cellular origin, and 
clinical manifestation (Kool et al., 2012; Li et al., 2013). However, while it has been shown that 
there are distinct tumor subsets within the Shh subgroup (Northcott et al., 2011), our novel model 
is the first to exhibit such drastic variation in treatment response for two tumors induced by the 
same oncogene but at different time points during in-utero development. G-Smo mice do not 
exhibit statistically significant differences in survival after RT. However, M-Smo mice fare 
significantly better and several mice witness complete disappearance of the tumor. Baseline cell 
counts of pH2Ax and cC3 confirm that G-Smo and M-Smo are similar tumors. Therefore, it is 
unlikely that differing responses to radiation result from innate tendencies of either genotype to 
have higher rates of DNA damage or apoptosis. IHC for pH2Ax after RT indicates that G-Smo 
mice are equally susceptible to radiation-induced DNA damage compared to M-Smo mice. 
Additionally, radiation resistance of G-Smo tumors does not appear to lie in an inability to 
activate apoptosis, as high levels of cC3 and TUNEL were witnessed in both tumors. A notable 
amount of tumor cells in the G-Smo appear to die off, as evidenced by the tumor’s spongy 
appearance in the H&E histology at 4 and 24 hours post radiation.  
However, unlike M-Smo mice which continue to witness tumor regression from 4 hours 
onward, G-Smo tumors recover and continue to proliferate at some point between 4 and 48 hours 
after RT. Although the distribution of DNA-damage positive nuclei appeared evenly widespread 
in both genotypes, activation of apoptosis appeared patchier in G-Smo mice. Both the DNA 
damage response protein p53, as well as indicators of apoptosis cC3 and TUNEL exhibited this 
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spotty appearance as well, suggesting that the G-Smo tumors can tolerate a greater level of DNA 
damage without initiating apoptotic pathways.  
It is possible that differences in DNA repair mechanisms account for the differential 
survival of G-Smo tumor cells. ATR is a DNA damage response protein, which helps activate a 
cell cycle checkpoint to induce DNA repair, halt replication, or initiate apoptosis. ATR levels via 
Western blot were found to decrease from 1 hour to 4 hours post radiation for G-Smo tumors and 
increase for M-Smo tumors. Down-regulation of ATR may help the G-Smo tumor cells avoid 
arresting in the cell cycle and undergoing apoptosis, thus allowing the cells to persist despite 
DNA damage. Alternatively, in M-Smo mice, there was an increase in ATR from 1 hour to 4 
hours, which suggests that increased ATR is correlated with the widespread apoptosis of M-Smo 
tumor cells, and activation of p53, leading to apoptosis. 
Another potential explanation for G-Smo tumor persistence after RT is greater variation 
within the cells that make up the G-Smo tumor. Cancer cells are known for their aberrant 
genetics and mutation frequency. It is possible that G-Smo tumor cells are more heterogeneous 
than M-Smo tumor cells; that is, that particular tumor cells within the G-Smo tumor and their 
resulting daughter cells vary more from their neighboring tumor cells than in M-Smo tumors. 
Thus, when radiation is broadly applied over the whole tumor, some cell populations will survive 
while others die, as was seen with the patches of G-Smo tumor which did not undergo apoptosis. 
These surviving cells could then repopulate the tumor. Heterogeneity of the G-Smo tumor is also 
supported by microarray data, as a notably larger number of genes were expressed with at least a 
twofold change after RT in G-Smo tumors (110) compared to M-Smo (48). Additionally, there 
appeared to be greater variety in the genes expressed by G-Smo mice. 45 of 48 genes altered by 
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M-Smo were also altered by G-Smo, but an additional 65 genes only exhibited a twofold change 
in G-Smo after RT.  
To examine what might contribute to the differential gene expression in the G-Smo mice 
compared to the M-Smo mice, I examined select histone modifications. While the G-Smo and 
M-Smo genomes are similar, expression of those genes may be impacted by epigenetic factors 
such as histone modifications. The Western blot results show that even before radiation, both 
methylation and acetylation patterns vary between G-Smo and M-Smo tumors. This was 
observed through Western blots of H3K9me and H2BK5 acetylation. This suggests that different 
genes are being made transcriptionally available to each genotype’s tumor cell populations 
before radiation, which can impact their response to RT. After RT, dot plots of histone families 
show a more marked change in histone gene expression in G-Smo (14 histone family genes) 
compared to M-Smo tumors (2 histone family genes). In addition, the changes are more 
pronounced for G-Smo samples. Combined with the observation that more genes are altered in 
G-Smo after RT than M-Smo, it is possible that G-Smo mice undergo more dynamic histone 
alterations after radiation, allowing them to more readily transcribe and express different genes 
that may contribute to radiation resistance.  
As cancer research progresses, there is a growing interest in epigenetic modifications 
between different tumor types. Histone modifications such as H3K4 and H3K27 methylations, 
which were examined in this model, have been shown to interact with promoter regions of 
several apoptosis-related genes, with levels of gene activation predicting cell line sensitivity to 
chemotherapy and RT (Benard et al., 2014). It would be of interest to examine methylation and 
acetylation patterns of different apoptosis and cell stress related genes in the G-Smo and M-Smo 
mice to determine if similar patterns could be observed. Additionally, histone-modifying proteins 
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have been targeted as a therapeutic treatment, with potential for promising results (Pajtler et al., 
2013). For example, knockdown of the histone demethylase KDM1A induced apoptosis and 
decreased proliferation of medulloblastoma cells in vitro (Jones et al., 2013; Pajtler et al., 2013). 
The response of G-Smo tumors in altering their histone families and changing gene expression 
after RT to produce a more active transcriptional response may underlie the ability of the tumor 
cells to survive. Further study into histone variations between radiation-resistant and radiation-
sensitive tumors would be of value to understand how tumors persist after radiation treatment. 
 
CONCLUSION 
I show that timing of oncogenesis results in two pathologically similar tumors with 
different radiation treatment outcomes. Upon radiation, differences in histology, protein 
quantities, and gene expression are notable between the two tumor genotypes. G-Smo mice 
exhibited tumor recurrence, “spotty” activation of apoptosis, and greater variation in gene 
expression post-radiation, particularly of histone family-related genes. Results suggest that the 
heterogeneity of response within the G-Smo tumor allow it to persist after radiation. 
Understanding the trends of genetic and transcriptional responses of resistant tumors may allow 
for future patients to undergo a screening ahead of time to determine if radiation would serve as 
an effective treatment. This is particularly important as many medulloblastoma cases occur in 
children and radiation treatment can adversely affect growth and development of normal brain 
tissue. Knowing genetic predictors of RT outcome would allow for more personalized and 
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